Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Amgen Inc (AMGN.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-02-15223.94235.00Neutral
2022-04-26249.87251.00Neutral
2022-04-27248.79245.00Neutral
2022-07-19247.32242.00Neutral
2022-08-05246.25248.00Neutral
2022-10-21251.94257.00Neutral
2022-11-06269.04271.00Neutral
2023-01-29253.65260.00Neutral
2023-02-01246.41245.00Neutral
2023-04-20243.46249.00Neutral
2023-05-01238.90248.00Neutral
2023-07-24235.42250.00Neutral
2023-08-04243.28260.00Neutral
2023-10-27261.57272.00Neutral
2023-11-01260.84268.00Neutral
2024-01-24305.50315.00Neutral
2024-01-26311.77314.00Neutral
2024-04-17264.07284.00Neutral
2024-05-03311.29307.00Neutral
2024-07-12330.83337.00Neutral
2024-08-07312.50335.00Neutral
2024-10-30315.54326.00Neutral
2024-12-16266.50280.00Neutral
2025-02-05307.81315.00Neutral
2025-04-14293.92319.00Neutral
2025-05-01283.78315.00Neutral

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.